View
219
Download
0
Category
Preview:
Citation preview
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 1/13
IV LATIN AMERICA RISK ASSESSMENT WORKSHOP
STUDY CASEMethyl Parathion: Occupational Exposure
and Risk Assessment
Déborah Mendes Máximo Cardozo
Veterinary
Enviromental Analist
IBAMA
2011
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 2/13
SUMMARY
1.INTRODUCTION.......................................................................................................................1
2.PHYSICAL AND CHEMICAL DATA.......................................................................................1
3.KINECT AND METABOLISM DATA......................................................................................2
3.1 Absorption................................................................................................................................2
3.2 Distribution..............................................................................................................................2
3.3 Metabolism..............................................................................................................................3
3.4 Elimination and Excretion.......................................................................................................3
4.TOXICITY DATA AND TOXICITY EVALUATION................................................................4
4.1 Acute Toxicity..........................................................................................................................4
4.2 Subchronic Toxicity.................................................................................................................4
4.3 Reproductive and Development Toxicity................................................................................4
4.4 Chronic Toxicity/Carcinogenicity...........................................................................................4
4.5 Genotoxicity and Mutagenicity...............................................................................................4
4.6 Immunotoxicity.......................................................................................................................4
4.7 Effects in Humans...................................................................................................................5
5.ECOTOXICOLOGICAL DATA................................................................................................5
6.EXPOSURE...............................................................................................................................6
7.TOXICITY, HARZARD AND RISK ESTIMATION................................................................7
8.RISK EVALUATION.................................................................................................................8
9.CONCLUSION...........................................................................................................................9
10.REFERENCES........................................................................................................................10
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 3/13
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 4/13
Common Name Methyl Parathion
Chemical NameO,O-dimethyl O-p-nitrophenyl
phosphorothioate
Chemical Family Organophosphate
CAS Registry Number 298-00-0
Empirical Formula C8H10O5 NPS
Molecular Weight 263.2 g/mole
Solubility
Solubility in water 55 - 60 mg/l (20°C); soluble
in most organic solvents, slightly soluble in
petroleum and mineral oils
logPow 3 - 3.43
Vapour Pressure 0.41 mPa (25 °C)
Melting Point 35 -36 °C
Reactivity Rapidly hydrolysed in alkaline conditions
3.KINECT AND METABOLISM DATA
Methyl parathion can be readily absorbed by humans following inhalation, oral, or dermal
exposure, although quantitative data are lacking. Studies in animals indicate that oral absorption
following single doses can amount to 80% of the administered dose within a few days of dosing. A
single dermal study in rats also suggested almost complete absorption of an applied dose within a96-hour period. No data are available regarding pulmonary absorption of methyl parathion in
animals.
Methyl parathion has been detected in human breast milk and studies in animals have shown
that it can cross the placenta and be transferred to the fetus. Methyl parathion is rapidly and
extensively metabolized, mainly in the liver, to polar substances that are quickly excreted in the
urine.
Oxidative desulfuration by microsomal oxidases transforms methyl parathion into the
neurotoxic, active metabolite, methyl paraoxon; the specific isozyme involved in this reaction has
not been identified. Other reactions including oxidation, hydrolysis, dearylation, and dealkylation
detoxify methyl parathion. A major detoxification pathway is enzymatic hydrolysis of methyl
paraoxon to dimethyl phosphate and 4-nitrophenol. These metabolites are eliminated primarily inthe urine in humans, rats, and mice.
3.1 Absorption
Often, absorption occurs by multiple routes in humans. Dean et al. (1984) reported deaths
and toxic effects as well as lowered blood cholinesterase levels and excretion of urinary 4-
nitrophenol in several children who were exposed by inhalation, oral, and possibly dermal routes
after the spraying of methyl parathion in a house. In the same incident (Dean et al. 1984),
absorption was indicated in adults who also excreted 4-nitrophenol in the urine, though at lower
levels than some of the children, and in the absence of other evidence of methyl parathion exposure.
In this study, the potential for age-related differences in absorption rates could not be assessed
2
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 5/13
because exposure levels were not known and the children may have been more highly exposed than
the adults.
3.2 Distribution
There is limited information available regarding the distribution of methyl parathion after
inhalation exposure in humans or animals. In relation to oral exposure studies, low systemicavailability of methyl parathion following oral gavage in dogs was suggested to be the result of
hepatic first-pass metabolism (Braeckman et al. 1983).
Furthermore, placental transfer of methyl parathion was demonstrated following oral
administration to pregnant rats 1–3 days before parturition. Thirty minutes after administration,
methyl parathion was found in fetal brain, liver, and muscle, and in the placenta and maternal liver,
suggesting its rapid distribution (Ackermann and Engst 1970).
Following single dermal applications of 10 mg/kg of radiolabeled methyl parathion to
pregnant rats, methyl parathion was found to be widely distributed to all major tissues and organs.
Concentrations were highest in plasma and kidney, maximum levels measured 2 hours
postapplication. Peak levels in liver, brain, fetus, and placenta, were measured 2 to 10 hours later, at
which times the highest concentration of methyl parathion was in the fetus (Abu-Quare et al. 2000).
3.3 Metabolism
Methyl parathion is a phosphorothioate, which refers to the organophosphate compounds
that contain the P=S substructure. The low systemic availability of methyl parathion after oral
administration in dogs, and the high hepatic extraction ratios after intravenous administration,
suggest first-pass metabolism by the liver. This compound can be activated (oxidative
desulfuration) to its toxic metabolite, methyl paraoxon. The proposed metabolic pathway is shown
in Figure 1.
Figure 1: Proposed Metabolic Pathways of Methyl Parathion
3.4 Elimination and Excretion
3
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 6/13
The available evidence suggests that excretion of methyl parathion metabolites in humansand animals following acute oral exposure is essentially the same and occurs rapidly. Excretion
occurs primarily via the urine and a study in rats also reported excretion of methyl parathion in the
milk (Golubchikov 1991).
Limited information was available regarding excretion in humans and animals after
inhalation exposure.
4.TOXICITY DATA AND TOXICITY EVALUATION
4.1 Acute Toxicity
Methyl parathion is highly toxic via oral and dermal routes. Rats appeared to be the most
sensitive species, among the laboratory animals treated with methyl parathion. In rats, the medianoral lethal doses (LD50) ranged between 6-50 mg/kg (Category I oral toxicant). The dermal rat LD 50
was 67 mg/kg (Category I dermal toxicant), indicating that the toxicity of methyl parathion via oral
route or via skin is comparable. Methyl parathion was classified as Category II inhalation toxicant,
and Category IV eye and skin irritant. An acute (single dose) oral exposure of rats to methyl
parathion caused decreases in the ChE activities in the brain, plasma and erythrocytes, cholinergic
signs, neurobehavioral effects and neuropathology.
4.2 Subchronic Toxicity
Inhibition of the ChE activities in brain, plasma and erythrocytes was the most sensitive
toxicological endpoint after subchronic exposures of rats to methyl parathion by oral and dermal
4
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 7/13
routes. Cholinergic signs (including constricted pupils, tremors, gait abnormalities, decreased
activity and abnormal breathing), impairment of the cognitive and motor functions and death were
observed in the oral and dermal studies (5 to 95-day treatment).
4.3 Reproductive and Development Toxicity
The reported effects of methyl parathion on reproduction included: alteration in the levels of the luteinizing hormone in serum and early menopause in humans, decreased pup survival in rats,
possible ovarian toxicity in rats and sperm abnormalities in mice.
Various methyl parathion-induced developmental effects were reported in rats, mice and
rabbits, including lower fetal body weight, increased resorption, reduced pup survival,
abnormalities and variations of ossification and cleft palate.
4.4 Chronic Toxicity/Carcinogenicity
Chronic dietary exposure to methyl parathion of rats produced decreases in the ChE
activities, neurological signs, hematological effects and nerve demyelination. The reduction of the
ChE activity in the mice brain was the most sensitive toxicological endpoint. Methyl parathion wasnot considered to cause cancers in laboratory animals.
4.5 Genotoxicity and Mutagenicity
Methyl parathion was genotoxic in in vitro and in vivo tests causing gene mutations in
bacteria, chromosomal aberrations in mammalian cells, sister chromatid exchange; and was
positive on the sex-linked recessive lethal assay in Drosophila. In vitro, methyl parathion was
shown to bind directly to the cellular DNA.
4.6 Immunotoxicity
Several studies from the open literature showed that methyl parathion has the potential to
alter the immune system. However, further research is needed to clearly identify the health
implications of some of these immunological changes.
The potential for immunotoxicity after long-term exposures was reported by Institoris et al.
(1995) in a 3-generation study in Wistar rats. Methyl parathion at 0, 0.218, 0.291, or 0.436 mg/kg
was administered via intubation, 5 days per week. The effects that were statistically significant
included: decrease in white blood cells, red blood cell, hematocrit, increase in medial red blood cell
cell volume, slight increase in relative liver weight and decrease in relative thymus weight, increase
in the nucleated cell contents in the femoral bone marrow, and dose-dependent decreases in plaque-
forming splenocytes with sheep erythrocytes.
4.7 Effects in Humans
Methyl parathion is a highly toxic pesticide, and humans are susceptible to its acute toxic
effects by various routes of exposure. Signs and symptoms of acute toxicity are typical of those
induced by organophosphate insecticides as a group. Almost all systemic effects of methyl
parathion are related to the action of this compound on the nervous system or are secondary to this
primary action. Methyl parathion and its active metabolite, methyl paraoxon, exert their profound
toxic effect by inhibiting the activity of acetylcholinesterase in the nervous system and at the motor
end-plate. Hydrolysis of acetylcholine is inhibited and the neurotransmitter accumulates at its site of
action, producing overstimulation of cholinergic end organs.
5
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 8/13
Information regarding effects in humans is limited to a few case reports of people acutely
exposed to high levels of methyl parathion either by intentional ingestion or by multiple-route
exposure from direct contact with spray material either in field applications or through illegal
indoor spraying. Manifestations of acute poisoning are similar in humans and animals and include
reduced cholinesterase levels in brain, erythrocytes, and plasma, clinical signs of neurological
effects such as tremors and convulsions, and cardiac arrhythmia. Except for neuropsychiatric
disorders reported in humans after chronic occupational exposure to organophosphates includingmethyl parathion, no chronic effects have been documented in humans.
5.ECOTOXICOLOGICAL DATA
Microorganisms can use methyl parathion as a carbon source and studies on a natural
community showed that concentrations of up to 5 mg/litre increased biomass and reproductive
activity. Bacteria and actinomycetes showed a positive effect of methyl parathion while fungi and
yeasts were less able to utilize the compound. A 50% inhibition of growth of a diatom occurred at
about 5 mg/litre. Cell growth of unicellular green algae was reduced by between 25 and 80 µg
methyl parathion/litre. Populations of algae became tolerant after exposure for several weeks.
Methyl parathion is highly toxic for aquatic invertebrates, most LC50s ranging from 1 µg to
about 40 µg/litre. A few arthropod species are less susceptible. The no-observed-effect level for the
water flea (Daphnia magna) is 1.2 µg/litre. Molluscs are much less susceptible with LC50
s ranging
between 12 and 25 mg/litre. Most fish species in both fresh and sea water have LC50
s between 6
and 25 mg/litre, a few species being substantially more or less sensitive to methyl parathion. The
acute toxicity of amphibians is similar to that of fish.
Population effects have been seen in communities of aquatic invertebrates in experimental
ponds treated with methyl parathion. The concentrations needed to cause these effects would occur
only with overspraying of water bodies and, even then, would last for only a short time. Population
effects are, therefore, unlikely to be seen in the field. Kills of aquatic invertebrates would be
unlikely to lead to lasting effects.Care should be taken to avoid the overspraying of ponds, rivers, and lakes, when using
methyl parathion. The compound should never be sprayed in windy conditions. Methyl parathion is
a non-selective insecticide that kills beneficial species as readily as pests. Kills of bees have been
reported following the spraying of methyl parathion. Effects on bees in methyl parathion incidents
were more severe than those of other insecticides. Africanized honey bees are more tolerant of
methyl parathion than European strains. Extreme care must be taken to time methyl parathion
spraying to avoid adverse effects on honey bees.
6.EXPOSURE
Skin absorption, and to a lesser extent inhalation and ingestion, are important routes of
exposure to methyl parathion. Mixers, loaders, flaggers, applicators and field workers are
particularly at risk. Dermal, ocular and inhalation exposure can occur during mixing, loading and
application, cleaning and repair of equipment, and during early reentry in treated areas.
Dermal contact is the predominant route of occupational exposures from the pesticidal use
of methyl parathion. Dermal absorption was evident in the detection of methyl parathion in the
blood, p-nitrophenol in the urine, and ChE inhibition among agricultural workers (Ware et al.,
1974). Without proper respiratory protection, inhalation of methyl parathion can also be a
significant route of occupational exposure. Newell and Dilley (1978) reported that formulating plant
workers protected by respirators had fewer cases of ChE inhibition and poisonings from exposures
6
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 9/13
to methyl parathion.
In Brazil this active ingredient is registered to crops of cotton, beans, corn, soybeans and
wheat in formulations as emulsifiable concentrate and microencapsulate with ranges from 400 to
600 g/L a.i. The figure below shows the amount of methyl parathion used in every state of Brazil.
Figure 2: Spatialization of Methyl Parathion sales in Brazil
7.
TOXICITY, HARZARD AND RISK ESTIMATION
The toxicity of methyl parathion is integral to assessing the occupational risk. All risk
calculations are based on the most current toxicity information available for methyl parathion. The
toxicological endpoints, and other factors used in this occupational risk assessments for methyl parathion are listed below.
Harzard Identification
Table 1: Acute Toxicological Categories for Methyl Parathion (Reregistration Eligibility
Decision – RED – for Methyl Parathion by U.S. Environmental Protection Agency)
Study Type Results Toxicity Category
Acute oral (rat) LD50 = 4.5 – 24 mg/kg I
Acute dermal (rat) LD50 = 6 mg/kg I
Acute inhalation (rat) LC50 = < 0.163 mg/L (7mg/kg) I
Primary eye irritation (rabbit) Irritation clear by 7 days III
7
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 10/13
Primary skin irritation Max. Score = 2.0; 72 h = 0.5 IV
Dermal sensitization Negative NA
Acute neurotoxicity delayed hen Negative NA
Methyl parathion is very toxic by oral, dermal, and inhalation routes, but is not a strong eye
or dermal irritant and is not a skin sensitizer.
Table 2: Endpoints of Sub-chronic and Chronic Studies (Reregistration Eligibility Decision – RED – for Methyl Parathion by U.S. Environmental Protection Agency)
Exposure Scenario Dose (mg/kg/day) Effect Study
*Short and Intermediate-
term dermal
LOAEL = 0,3Inhibition of brain and
RBC AChE. No NOAEL
identified.
28-Day dermal
toxicity study in rats.
*Short and Intermediated-
term Inhalation
NOAEL = 0,11
Neuropathology and
inhibition of brain,
plasma, and RBC AChE.
Inhalation absorption rate
estimated to be 100%.
One year dietary
neurotoxicity study
in rats.
Cancer Classification: Group “E” or “Not Likely”
*Short- (1 – 30 days) and Intermediate- term (1 – 6 months)
LOAEL = Lowest Observed Adverse Effect Level
NOAEL = No Observed Adverse Effect Level
UF = Uncertainty Factor
RBC = Red Blood Cell
Exposure Assesment
This paper pertains only to the assessment of the occupational exposure to methyl parathion.The human exposure to methyl parathion from occupational activities was expressed as an average
daily dose of exposure (ADD).
ADD = (Unit of exposition) x (aplication rate/frequency) x (ha/day) x (% absorption)
body weight
Handler exposure assessments were completed using a baseline exposure scenario that were
assessed with PHED (Scenarios 28 and 29) and with chemical specific data.
Risk Estimation
Risk for all of potentially exposed populations is measured by a Margin of Exposure (MOE)
which determines how close the occupational or residential exposure comes to a No Observed
Adverse Effect Level (NOAEL). Generally, MOEs greater than 100 do not exceed the risk concern.
The critical NOAELs for characterizing the risk from exposure to methyl parathion were derived
from studies with laboratory animals.
MOE = NOAEL
ADD
Considering that workers are exposed to dermal and inhalation route, the MOE is calculated
like a aggregate Margin of Exposure (MOE):
8
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 11/13
MOE total = 1
1 + 1
MOE dermal MOE inhalation
8.RISK EVALUATION
Scenario and Evaluation
The scenario that will analyzed in this section is the exposition of a person mixing, loading
and applying a formulation (emulsifiable concentrate) containing 600 g a.i/L in a soy crop using a
groundboom sprayer with or without Personal Protective Equipment (PPE) .
This situation was selected because parathion methyl is one of the pesticides used to control
insect pests in this important crop in Brazil. The products containing this active ingredient are a
cheap option to producers and because of that they are widely used.
The duration of exposure for handlers of methyl parathion is assumed to be short-and
intermediate-term (1-30 days; 1-6 months). Since methyl parathion is applied to several large
acreage crops (500 until 2.000 ha), it is assumed that a professional pesticide applicator could applymethyl parathion for over one month, then the most important endpoints that will be used are the
relacionated to sub-chronic and chronic studies. Since short- and intermediate-term exposures have
the same endpoints, the following risks are for both durations of exposure. The table 3 summarized
the informations about the scenario described.
Table 3: Scenario Summary
Exposure ScenarioAplication Rate
(kg a.i/ha)Crop
Daily treated area
(ha/day)
Applying liquids with a
groundboom sprayer (ECformulation)
0,6 kg a.i/ha Soy 30
Based on the scenario data, values of the table 2 and the equations (ADD and MOE) the
calculations about occupational risk of methyl parathion were made.
Unit of exposition = 1,9400694 (Dermal)/2,8660117 (Inhalation) – Scenario 28 (No PPE)
0,079366 (Dermal)/2,8660117 (Inhalation) – Scenario 28 (PPE)
0,4850173 (Dermal)/0,7716185 (Inhalation) – Scenario 29 (No PPE)
0,0639341 (Dermal)/0,7716185 (Inhalation) – Scenario 29 (PPE)Rate of application/frequency = 0,6 kg a.i/ha
% Absorption: 100% (1.0 for inhalation) – 100% (1.0 for dermal)
Treated area = 30 ha/day
In this evaluation was considered 100% of dermal absorption because lack of informations
about this parameter in the selected studies. Furthermore, the LOAEL of 0,3 mg/kg/day was divided
by 3 (UF) to extrapolate from a LOAEL to a NOAEL. Then the adjusted NOAEL = 0,1 mg/kg/day.
Dermal and inhalation risks for handlers were combined into a total MOE since the effects
seen at the LOAEL were the same.
9
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 12/13
8/3/2019 Study Case Methyl Parathion
http://slidepdf.com/reader/full/study-case-methyl-parathion 13/13
Abu-Qare AW, Abdel-Rahman AA, Kishk AM, et al. 2000. Placental transfer and pharmacokinetics
of a single dermal dose of methyl parathion in rats. Toxicol Sci 53:5-12.
Agency for toxic substances and disease registry (ATSDR) 2001. Toxicological profile for methyl
parathion Atlanta, GA:US. Departament of Healthy and Human Services, Public Healthy Services.
Ackermann H., Engst R. 1970. Presence of organophosphorus insecticides in the fetus. Arch
Toxicol 26:17-22.
Braeckman RA., Audenaert P. Willems J. L., et al. 1983. Toxicokinects of methyl parathion and
parathion in the dog after intravenous and oral administration. Arch Toxicol 54:71-82.
Dean A., Pugh J., Embrey K., et al. 1984. Organophosphate insecticide poisoning among siblings –
Mississipi. MMWR 33:592-594.
Golubchikov MV. 1991. Toxicological substantiation of the safe use of xenobiotics. Gig. San.
(1):56-58.
Guia de Exposição Suplementar do PHED. Estimativas de Exposição Ocupacional - ThePesticide Handler Database Version 1.1. 1998.
Institoris, L., Siroki, O. and Desi, I. 1995. Immunotoxicity study of repeated small doses of
dimethoate and methylparathion administered to rats over three generations. Hum. Experi. Toxicol.
14:879-883.
Newell, G. W. and Dilley, J. V. 1978. Teratology and Acute Toxicology of Selected Chemical
Pesticides Administered by Inhalation. United States Environmental Protection Agency, Office of
Research and Development, Cincinnati, Ohio. Report No. 600/1-78-003, PB277-007.
Ware, G. W., Morgan, D. P., Estesen, B. J. and W. P. Cahill. 1974. Establishment of reentry
intervals for organophosphate-treated cotton fields based on human data. II. Azodrin, ethyl and
methyl parathion. Arch. Environ. Contam. Toxicol. 2:117-129.
11
Recommended